BioCryst Pharmaceuticals Statistics
NASDAQ: BCRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
8.40+0.45 (+5.66%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BioCryst Pharmaceuticals by the numbers
BioCryst Pharmaceuticals has a market capitalization of $2.15 billion based on 255.54M shares outstanding. With trailing EPS of $-1.40, BioCryst Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.4% below its 50-day average and 3.3% below its 200-day average.
Average daily trading volume is 4.09M shares, or about $34.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BCRX valuation vs. peer median
| Metric | BCRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.15B | $2.18B | -2% |
| Forward P/E | 8.9 | 28.1 | -68% |
| Avg. volume | 4.09M | 1.46M | +180% |
Peer median across 8 companies: ALVO, VCEL, ADMA, RXRX, VIR, MESO, BEAM, TARS.
Valuation
- Market cap
- $2.15B
- Forward P/E
- 8.94
- EPS (TTM)
- $-1.40
- Shares outstanding
- 255.54M
Price and trading
- Previous close
- 7.95
- Open
- 7.91
- Day range
- 7.86 – 8.43
- 52-week range
- 6.00 – 11.22
- 52-week change
- +20.86%
- Beta
- —
- Volume
- 5.11M
- Average volume
- 4.09M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 2.15B
- Forward Pe
- 8.94
- Eps
- -1.40
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 11.22
- Week52 Low
- 6.00
- Avg Volume
- 4.09M
- Shares Outstanding
- 255.54M
- Ma50
- 9.17
- Ma200
- 8.69
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -25.13%
- Pct From52w Low
- 40.00%